Modernization of private drug plan policies, as well as looking at employee health outcomes in comparison to drug coverage were two issues discussed at the 4th Annual Benefits Advisors’ Drug Plan Outlook. Mapol Inc. brought together benefits advisors from across Canada with representatives of Canada’s brand pharmaceutical manufacturers on December 5, 2017. The purpose of this meeting was to review key developments and trends that occurred in 2017 within the benefits industry as they pertain to drug plan policies.